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Background and Aims: The systemic host response in sepsis is frequently
accompanied by central nervous system (CNS) dysfunction. Evidence suggests that
excessive formation of neutrophil extracellular traps (NETs) can increase the permeability
of the blood–brain barrier (BBB) and that the evolving mitochondrial damage may
contribute to the pathogenesis of sepsis-associated encephalopathy. Kynurenic acid
(KYNA), a metabolite of tryptophan catabolism, exerts pleiotropic cell-protective effects
under pro-inflammatory conditions. Our aim was to investigate whether exogenous KYNA
or its synthetic analogues SZR-72 and SZR-104 affect BBB permeability secondary to
NET formation and influence cerebral mitochondrial disturbances in a clinically relevant
rodent model of intraabdominal sepsis.
Methods: Sprague–Dawley rats were subjected to fecal peritonitis (0.6 g kg-1 ip) or a
sham operation. Septic animals were treated with saline or KYNA, SZR-72 or SZR-104
(160 µmol kg-1 each ip) 16h and 22h after induction. Invasive monitoring was performed
on anesthetized animals to evaluate respiratory, cardiovascular, renal, hepatic and
metabolic parameters to calculate rat organ failure assessment (ROFA) scores. NET
components (citrullinated histone H3 (CitH3); myeloperoxidase (MPO)) and the NET
inducer IL-1b, as well as IL-6 and a brain injury marker (S100B) were detected from
plasma samples. After 24h, leukocyte infiltration (tissue MPO) and mitochondrial complex
I- and II-linked (CI–CII) oxidative phosphorylation (OXPHOS) were evaluated. In a separate
series, Evans Blue extravasation and the edema index were used to assess BBB
permeability in the same regions.
Results: Sepsis was characterized by significantly elevated ROFA scores, while the
increased BBB permeability and plasma S100B levels demonstrated brain damage.org August 2021 | Volume 12 | Article 7171571
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Frontiers in Immunology | www.frontiersin.Plasma levels of CitH3, MPO and IL-1b were elevated in sepsis but were ameliorated by
KYNA and its synthetic analogues. The sepsis-induced deterioration in tissue CI–CII-
linked OXPHOS and BBB parameters as well as the increase in tissue MPO content were
positively affected by KYNA/KYNA analogues.
Conclusion: This study is the first to report that KYNA and KYNA analogues are potential
neuroprotective agents in experimental sepsis. The proposed mechanistic steps involve
reduced peripheral NET formation, lowered BBB permeability changes and alleviation of
mitochondrial dysfunction in the CNS.Keywords: N-methyl-D-aspartate receptor, blood-brain barrier, mitochondrial respiration, brain injury, neutrophil
extracellular trapINTRODUCTION
Sepsis is defined as a dysregulated host response to infection,
which can lead to life-threatening organ failure (1). The brain is
among the potentially injured vital organs; and central nervous
system (CNS) abnormalities assessed by sequential organ failure
assessment (SOFA) scores can be present in up to 70% of
patients, in association with higher mortality (2, 3).
Although the pathomechanism of sepsis-associated
encephalopathy is not fully understood, it is recognized that
the CNS responds to peripheral cytokine release through an
increase in blood–brain barrier (BBB) permeability (4). BBB
leakage associated with edematous cerebral cortex lesions (5–7)
and injury of hippocampal-cerebellar structures have already
been identified at the early phase (~6–8h) of various models of
sepsis (8). In parallel with damage to BBB integrity, infiltration of
activated polymorphonuclear leukocytes into brain tissues also
occurs (9). The activation of circulatory leukocytes with
neutrophil extracellular trap (NET) formation leads to
excessive release of proteases and generation of reactive oxygen
species (ROS), which exacerbates BBB damage (10–12). NETs
are web-like DNA and intracellular protein structures with
constant components, such as histones, myeloperoxidase
(MPO) and neutrophil elastase, while other components
depend on stimuli, e.g., pathogens, cytokines, antibodies and
immune complexes (13). Most importantly, a regulated form of
neutrophil cell death with NET formation defined as NETosis
correlates with the severity of organ failure (14).
Along with BBB injury and immune activation, cerebral
mitochondria are also affected soon after an inflammatory
insult (~12–24h) at least in rodent experiments. Functional
and morphological changes within the organelles and changes
in microglial energy metabolism (15) have been demonstrated,
manifested by decreased respiratory chain function and oxidative
phosphorylation (OXPHOS) (16) and loss of mitochondrial
membrane potential (DYmt) (17). These events may ultimately
lead to a release of mitochondrial damage-associated molecular
patterns to the extracellular space, which further stimulate the
immune response. In addition, mitochondria-driven
inflammation may contribute to cell death, multiorgan failure
or long-term cognitive dysfunction as well (18–20).org 2In this context, it has been shown that the neuronal
N-methyl-D-aspartate receptors (NMDA-Rs) can play an
important role in sepsis-induced neuroinflammation and
sensory dysfunction, but the underlying molecular mechanisms
remain unknown (21, 22). Kynurenic acid (KYNA), a metabolite
of the tryptophan–L-kynurenine pathway, is a naturally
occurring antagonist of NMDA-R and acts as an endogenous
neuroprotectant in a number of brain diseases (23).
Furthermore, exogenously administered KYNA exerted cell-
protective effects in neuronal (23) and non-neuronal tissues
(e.g., liver and intestine) (24) in various pro-inflammatory
circumstances. In addition to glutamate receptor antagonism,
KYNA acts as an agonist for G protein-coupled receptor GPR35
and the aryl hydrocarbon receptor and regulates glutamatergic
neurotransmission and immune activation (25). Previously, we
have already shown that KYNA and its synthetic analogue,
termed SZR-72, ameliorated sepsis induced mitochondrial
dysfunction (decreased oxygen consumption and DYmt) in the
rat liver (17). Nevertheless, the mitochondrial effects of these
compounds in the CNS have not been examined before.
Given this background, the main goal of our study was to
characterize the mechanism of a KYNA-based therapy
specifically targeted for brain neuroprotection during a septic
reaction. We hypothesized that exogenously administered
KYNA and its BBB-permeable synthetic analogues (SZR-72
and SZR-104) might be therapeutic tools to reduce
mitochondrial disturbances in the CNS by influencing
peripheral NET formation and BBB permeability in a clinically
relevant rodent model of intraabdominal sepsis.MATERIALS AND METHODS
Animals
The experiments were performed on male Sprague–Dawley rats
(n∑=77; 410 ± 30 g) housed in plastic cages (21–23°C) with a 12/
12h dark/light cycle and access to standard rodent food and
water ad libitum. The study was performed in accordance with
the National Institutes of Health guidelines on the handling and
care of experimental animals and EU Directive 2010/63 for the
protection of animals used for scientific purposes, and it wasAugust 2021 | Volume 12 | Article 717157
Poles et al. Kynurenic Acid-Based Sepsis Therapyapproved by the National Scientific Ethical Committee on
Animal Experimentation under license number V/175/2018.
Sepsis Induction and Treatments
The animals were randomly divided into sham-operated (n∑=15)
and septic groups (n∑=62). Polymicrobial sepsis was induced
with intraperitoneally (ip)-administered fecal inoculum, as
described before (17, 26). Briefly, fresh feces samples were
randomly collected from healthy rats (n=4–5), suspended and
incubated in physiological saline (37°C, 5h). After filtering, the
count for colony forming units (CFUs) in the suspension used
for sepsis induction was determined with the standard poured
plate count method. This analysis retrospectively demonstrated
that the CFU range of the inducer inoculum was 1.02×106–
5.6 ×106 CFU mL-1. Rats in the sham-operated groups received
the same amount of saline ip. The septic animals were further
divided into saline-treated (n=17), KYNA- (Sigma-Aldrich Inc.,
St. Louis, MO, USA; 160 mmol kg−1 ip; n=15), SZR-72- [N-(2-
(dimethylamino)ethyl)-4-hydroxyquinoline-2-carboxamide
hydrochloride, 160 mmol kg−1 ip; n=15] or SZR-104- [N-(2-
( d ime thy l am ino ) e t h y l ) - 3 - (morpho l i nome thy l ) - 4 -
hydroxyquinoline-2-carboxamide, 160 mmol kg−1 ip; n=15]
treated groups. Both SZR-72 and SZR-104 were synthesized by
the Institute of Pharmaceutical Chemistry, University of Szeged,
Hungary (27, 28). The compounds can be classified into acid
(KYNA), amide (SZR-72) and aminoalkylated amide (SZR-104)
derivatives. All bear the crucial 4-hydroxyquinoline-2-carboxyl
scaffold (i.e. KYNA); however, one or two tertiary nitrogen
bearing groups have been built-in. Thus, SZR-72 contains one
cationic center, while SZR-104 contains two cationic centers,
which has been previously proved to be responsible for better
BBB-penetration (28) and could result in different biological
effects. Treatments were performed in two steps (80 µmol kg-1; in
3 mL kg-1 saline each; pH=7.2–7.4) 16h and 22h after
sepsis induction.
Monitoring of Animal Well-Being
The general condition of the animals was evaluated at 6h and 16h
after the induction of sepsis using a modified 0–9-point rat-
specific sickness (RSS) scoring system, where a cumulative value
above 6 was considered a humane endpoint for euthanasia
(Supplementary Table S1). At the time of the RSS
assessments, the animals received 10 mL kg-1 crystalloid
solution subcutaneously (sc) (Ringerfundin, B. Braun,
Hungary) to avoid dehydration and 15 µg kg-1 buprenorphine
sc (Bupaq, Merck, USA) to maintain analgesia according to the
Minimum Quality Threshold in Preclinical Sepsis Studies
(MQTiPSS) recommendations (29).
Experimental Protocol
The experiments were performed in two series (Figure 1). In
Experimental Series I, sepsis-induced pathological changes in
NETosis were estimated, and cerebral mitochondrial respiration
analyzed. A second series of experiments had to be established to
measure the BBB permeability of the cerebellum and
hippocampus using the fluorescence Evans Blue technique toFrontiers in Immunology | www.frontiersin.org 3avoid methodology interference with the fluorescent dye
(see later).
Experimental Series I – Assessment of
NETosis and Mitochondrial Functions
Surgical Interventions and Sampling
At 22h of sepsis, the animals were anesthetized ip with a mixture
of ketamine (45.7 mg kg−1) and xylazine (9.12 mg kg−1). The rats
were placed on a heating pad to maintain normal core body
temperature (37°C). After tracheostomy, mechanical ventilation
(Inspira Advanced Safety Ventilator 55-7058; Harvard Apparatus
Inc., Holliston, MA, USA) was started with 7–8 mL kg-1 volume
of room air. The ventilation parameters (tidal volume and breath
rate) were set up based on arterial blood gas values (see later).
PE50 tubing was placed into the right jugular vein to administer
fluid infusion (10 mL kg-1 h-1 Ringerfundin iv) and to maintain
anesthesia (ketamine 12 mg kg-1 h-1, xylazine 2.4 mg kg-1 h-1 and
diazepam 0.576 mg kg-1 h-1 iv). The left carotid artery was also
cannulated for continuous monitoring of the heart rate (HR) and
the mean arterial pressure (MAP; SPEL Advanced Cardiosys 1.4;
Experimetria Ltd., Budapest, Hungary). After the 30-min
stabilization period, lactate levels of the venous blood were
measured (Accutrend Plus Kit; Roche Diagnostics Ltd.,
Rotkreuz, Switzerland) to determine metabolic imbalance. MAP
and HR data were recorded, and arterial blood samples were
collected for blood gas analysis (Cobas b123; Roche Ltd., Basel,
Switzerland). After 60 min of monitoring, HR and MAP values
were registered, and arterial and venous blood samples were
collected for blood gas analysis. Based on a standard formula
(SaO2–SvO2)/SaO2), simplified oxygen extraction (OER) was
calculated from arterial (SaO2) and venous oxygen saturations
(SvO2). Lung function was determined by calculating the PaO2/
FiO2 ratio (Carrico index) from partial arterial oxygen pressure
(PaO2) and fraction of inspired oxygen (FiO2), which was 0.21.
Following a median laparotomy, blood samples were collected
from the inferior vena cava into pre-cooled EDTA-coated tubes,
centrifuged (1200 g at 4°C for 10 min) and stored at -70°C for
later analysis. The rats were then sacrificed under deep
anesthesia, followed by a quick decapitation. After the removal
of the skin and skull bones, the hippocampus and cerebellum
were dissected for analysis of mitochondrial respiratory
functions and tissue MPO determination (Figure 1).
Experimental Series II – Measurement of
Blood–Brain Barrier Permeability
In the second series, sepsis induction, treatments with KYNA or
KYNA analogues and the surgical preparations were identical
with Experimental Series I (sham-operated n=7; saline-treated
sepsis n=7; KYNA- n=7; SZR-72 n=7 and SZR-104-treated sepsis
n=7, respectively). Following the hemodynamic and arterial
blood gas measurement, Evans Blue (EB) dye was injected iv
for the determination of BBB permeability as described earlier
(30) (Figure 1).
Briefly, 2% EB (1 mL kg-1 dissolved in saline; Sigma-Aldrich
Inc.) iv bolus was injected 23h after sepsis induction. After a 20-min
circulation of the tracer, animals were perfused transcardially withAugust 2021 | Volume 12 | Article 717157
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liver was cleared and a colorless washing fluid appeared from the
right atrium. After decapitation, the hippocampus and cerebellum
were dissected and wet weight measurements were performed to
calculate wet tissue/body weight ratio. Cerebral tissues were
homogenized in trichloroacetic acid (50%, Sigma-Aldrich Inc.) to
extract the dye from the tissue. After centrifugation (10,000 g, 4°C,
20 min), supernatant was collected and diluted 3:1 with ethanol
(70%, Sigma-Aldrich Inc.). Fluorescence intensity was determined
at a wavelength of 680 nm (RF-6000 Spectrofluorometer, Shimadzu
Corporation, Kyoto, Japan), and tissue EB content was quantified
from a standard linear curve derived from known amounts of dye
and expressed in ng g-1 tissue.
Rat Organ Failure Assessment
Rat organ failure assessment scores (ROFA) (17) were calculated
based on the idea of adapting the SOFA scoring system to rats. The
components were scored between 0 and 4 based on threshold
values determined earlier. Lung function was assessed by
calculating the Carrico index (PaO2/FiO2 ratio). Cardiovascular
function was evaluated from MAP values registered during theFrontiers in Immunology | www.frontiersin.org 4monitoring phase. Metabolic imbalance caused by tissue hypoxia
was indicated by blood lactate levels. Severity of kidney injury was
determined from plasma urea levels, whereas liver dysfunction was
assessed by measuring plasma alanine aminotransferase (ALT)
levels using a Roche/Hitachi 917 analyzer (F. Hoffmann–La Roche
AG, Switzerland). Rats with ROFA scores above 2 were considered
as septic (Table 1).
Measurement of Cerebral
Mitochondrial Functions
Mitochondrial oxygen consumption was assessed from the
cerebellum and hippocampus using High-Resolution
FluoRespirometry (17) (Oxygraph-2k; Oroboros Instruments,
Innsbruck, Austria). In brief, the whole brain was removed
rapidly, and the cerebellum and both the left and right
hippocampi were dissected on a pre-cooled Petri dish. The
remaining blood was washed out with ice-cold phosphate-
buffered saline (pH 7.4). Tissue samples were weighed on an
analytical balance (Precisia100A-300M; Precisa Gravimetrics AG,
Dietikon, Switzerland), cut into small pieces (~10–15 mg) with a
sharp scissors and then homogenized in five times the amount ofFIGURE 1 | The schemes for the experimental protocols (groups, interventions and assessments). In Series I, sampling for NETosis parameters and measurements
of brain mitochondrial oxygen consumption were conducted, whereas blood–brain barrier permeability measurements were performed in Series II. The animals were
randomly assigned to sham-operated or septic groups, which later was further divided into four independent groups according to the treatment (saline, KYNA, SZR-
72 or SZR-104) applied at the 16th and 22nd hours of sepsis.August 2021 | Volume 12 | Article 717157
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measurements were performed under continuous stirring
(750 rpm) at 37°C in a 2mL Mir05 respiration medium. After a
stable baseline respiration had been achieved, LEAK respirations
were evaluated after the oxidation of complex specific substrates: 10
mM glutamate, 2 mM malate (complex I-linked respirations;
LEAKGM) or 10 mM succinate (complex II-linked respirations;
LEAKs). Maximal capacities of oxidative phosphorylation
(OXPHOS I and OXPHOS II) were achieved by saturating
concentration of ADP (2.5 mM). Reverse electron transport-
derived ROS production was inhibited with rotenone (complex I
inhibitor; 0.5 mM), prior to the addition of succinate. The
cytochrome c test (cytc; 10 mM) was used after the addition of
ADP to assess the integrity of the outer membrane. ATP synthase
was inhibited by oligomycin (2.5 mM) to evaluate LEAK respiration
in a non-phosphorylating state (LEAKOmy). Electron transport-
independent respiration (or residual oxygen consumption; ROX)
was determined following complex III inhibition with antimycin A
(2.5 mM). The respiratory control ratio (RCR), an index of coupling
between respiration and phosphorylation, was expressed as a ratio
of OXPHOS to LEAKOmy state. The DatLab software (Oroboros
Instruments, Innsbruck, Austria) was used for online display,
respirometry data acquisition and analysis. Mitochondrial oxygen
consumption was normalized to wet weight (cerebellum: 19 mg and
hippocampus: 25 mg) and expressed in pmol s−1 mL−1.
Measurements of Inflammatory Markers
and Indices of NET Formation
Tissue and Plasma Myeloperoxidase
Circulating MPO level was regarded as an indicator of systemic
neutrophil activation and NET formation, whereas MPO being
retrieved from tissues (31) was regarded as a marker of
neutrophil granulocyte infiltration in brain tissue. Plasma
MPO level was detected from 100 µL undiluted plasma, while
the tissue MPO content was measured after a 2-step extraction
method from the pellet of the cerebral homogenate. The latter
data were referred to the protein content of the sample and were
given in mU mg protein-1.
Plasma Levels of Interleukin 6, Interleukin 1b,
Citrullinated Histone H3, and S100B
Sandwich enzyme-linked immunosorbent assay (ELISA) kits
were used to quantify proinflammatory cytokine interleukin 6
(IL-6; BioLegend, San Diego, CA, USA), NETosis inducerFrontiers in Immunology | www.frontiersin.org 5interleukin 1b (IL-1b; R&D Systems, Inc., Minneapolis, MN,
USA), NETosis-related biomarker citrullinated histone H3 (Cit
H3; MyBioSource, Inc., San Diego, CA, USA) and brain/BBB
injury marker S100B (MyBioSource, Inc., San Diego, CA, USA).
All measurements of plasma samples were carried out according
to the manufacturers’ instructions.
Statistical Analysis
The sample size estimation was based on a power analysis using
the PS Power and Sample Size Calculation software (version
3.1.2). Data analysis was performed using a statistical software
package (SigmaStat for Windows; Jandel Scientific, Erkrath,
Germany). Normality of data distribution was analyzed with
the Shapiro–Wilk test. Differences between groups were
calculated by either one-way analysis of variance (ANOVA)
completed with the Holm–Sidak post-hoc test or Kruskal–
Wallis one-way ANOVA on ranks followed by Dunn’s method
depending on the distribution of the data. Median values and
75th and 25th percentiles are provided in the figures; P<0.05 were
considered significant.RESULTS
Characterization of Sepsis Progression
Changes in Oxygen Dynamics, Inflammatory Marker,
and Organ Dysfunction Score
The overall health condition of the septic animals in all the
groups deteriorated significantly to the same extent 16h after
sepsis induction, as shown by the RSS scores (Supplementary
Figure S1).
When compared to the sham-operated animals, the saline-
treated septic animals showed lower OER, but higher IL-6 and
organ dysfunction (ROFA) scores 24h after sepsis induction
(Figures 2A–C). The OER values in the SZR-72-treated septic
animals, however, did not significantly differ from those of the
sham-operated animals (Figure 2A). IL-6 and ROFA score
elevations similar to those in the non-treated septic group were
also evident in the septic groups treated with KYNA, SZR-72 and
SZR-104 (Figures 2B, C). All the components of the ROFA score
showed significantly higher values in the saline-treated septic
animals than in the sham-operated animals (Supplementary
Table S2). Although the PaO2/FiO2 ratio and plasma levels of
ALT and urea were similar to those in the sham-operatedTABLE 1 | Threshold values of the components of the rat-specific organ failure assessment (ROFA) scoring system. Sepsis was defined as cumulative ROFA score
above 2.
Score ROFA parameters
Respiratory system Cardiovascular system Metabolism Renal function Liver function
PaO2/FiO2 ratio MAP (mmHg) blood lactate (mmol L
-1) plasma urea (mmol L-1) plasma ALT (U L-1)
0 400< 75< <1.64 <7.5 <17.5
1 300–400 65–75 1.64–3 7.5–21 17.5–30.2
2 200–300 55–65 3–4 21< 30.2<
3 100–200 <55 4–5 – –
4 – – 5< – –August 2021 | Volume 12 | Article 717157
Poles et al. Kynurenic Acid-Based Sepsis Therapyanimals in all the treated groups, we highlight that SZR-72 was
able to significantly reduce the liver damage caused by sepsis.
Despite this, these treatments did not influence the overall
ROFA score.
Changes in Blood–Brain Barrier Permeability and
Brain Damage
Sepsis caused a significantly higher wet tissue/body weight ratio
in the brain regions studied as compared with those in the sham-
operated animals. However, these local manifestations of brain
edema reached a lower extent in the hippocampus in all three of
the treated septic groups and in the cerebellum in the septicFrontiers in Immunology | www.frontiersin.org 6groups treated with SZR-72 and SZR-104 (Supplementary
Figure S2).
Sepsis induced a significant increase in BBB permeability in
the hippocampus and cerebellum as detected by the Evans Blue
method (Figures 3A, B), which was not substantially influenced
by any of the treatments in the cerebellum (Figure 3A). In the
case of the hippocampus, EB extravasation reached a similar
extent to that in the sham-operated group in all three of the
treated septic groups (Figure 3B).
The plasma level of S100B was used as a marker of brain
damage and an indirect measure of BBB disruption. Significantly
higher S100B levels were observed in the saline- and SZR-72-A
B
C
FIGURE 2 | Oxygen extraction ratio (OER, A), plasma IL-6 levels (B) and rat-
specific organ failure assessment (ROFA) score (C) in the sham-operated
group and in the different sepsis groups treated with saline, KYNA, SZR-72
and SZR-104. The plots demonstrate the median (horizontal line in the box)
and the 25th (lower whisker) and 75th (upper whisker) percentiles. Kruskal–
Wallis test and Dunn’s post-hoc test; *P < 0.05 vs. sham-operated group.A
B
C
FIGURE 3 | Blood–brain barrier permeability detected by the tissue levels of
Evans Blue (EB) in the cerebellum (A) and hippocampus (B) and changes in
plasma S100B levels (C) in a sham-operated group and in different sepsis
groups treated with saline, KYNA, SZR-72 and SZR-104. The plots
demonstrate the median (horizontal line in the box) and the 25th (lower whisker)
and 75th (upper whisker) percentiles. Kruskal–Wallis test, Dunn’s post-hoc test;
*P < 0.05 vs. sham-operated group; xP < 0.05 vs. sepsis+saline group.August 2021 | Volume 12 | Article 717157
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animals, whereas this parameter was markedly lower in response
to SZR-104 treatment than that in the saline-treated septic
group (Figure 3C).
Changes in Markers of NET Formation
Plasma levels of IL-1b (an inducer of NETs) and CitH3 and
MPO (the latter two being components of NETs formation)
showed significantly higher plasma levels in the saline-treated
septic groups than in any of the other groups (Figures 4A–C).
Furthermore, no differences from the sham-operated groups
were detected in any of the treated septic groups in theseFrontiers in Immunology | www.frontiersin.org 7parameters. As compared to the values of the saline-treated
sepsis groups, all the treatments resulted in significantly lower
CitH3 and MPO values (Figures 4B, C), whereas IL-1b was
lower only in response to SZR-104 treatment (Figure 4A).
Sepsis also caused significant increases in tissue MPO content
(an indicator of neutrophil leukocyte infiltration) in both
hippocampal and cerebellar tissues (Figures 5A, B). These
elevations were not present in the cerebellum in any of the
treated groups, and all three treatments resulted in significantly
lower tissue MPO values than untreated sepsis. In the
hippocampus, higher tissue MPO values were also present in
the KYNA and SZR-104-treated animals than those of the sham
operation, but also significantly lower levels were evident in
response to all three treatments than those after the saline
treatment (Figure 5B).
Changes in Cerebral Mitochondrial Functions
As a result of sepsis, both cerebellar and hippocampal complex I-
linked respirations were significantly reduced, as indicated by
decreased oxidation of complex I-linked substrates (LEAKGM),
ADP-stimulated respiration (OXPHOS I) and respiratory
acceptor control ratios (RCR I; Figures 6A, B). Neither KYNA
nor KYNA analogues restored the sepsis-induced decrease in
complex I-linked OXPHOS capacity, and RCR values remainedA
B
C
FIGURE 4 | Plasma IL-1b (A), citrullinated histone H3 (CitH3, B) and
myeloperoxidase levels (MPO, C) in a sham-operated group and in different
sepsis groups treated with saline, KYNA, SZR-72 and SZR-104. The plots
demonstrate the median (horizontal line in the box) and the 25th (lower
whisker) and 75th (upper whisker) percentiles. (A) Kruskal–Wallis test, Dunn’s
post-hoc test; (B, C) One-way ANOVA, Holm–Sidak post-hoc test; *P < 0.05
vs. sham-operated group; xP < 0.05 vs. sepsis+saline group.A
B
FIGURE 5 | Cerebellar (A) and hippocampal (B) levels of myeloperoxidase
(MPO) in the sham-operated group and in the different sepsis groups treated
with saline, KYNA, SZR-72 and SZR-104. The plots demonstrate the median
(horizontal line in the box) and the 25th (lower whisker) and 75th (upper
whisker) percentiles. Kruskal–Wallis test, Dunn’s post-hoc test; *P < 0.05 vs.
sham-operated group; xP < 0.05 vs. sepsis+saline group.August 2021 | Volume 12 | Article 717157
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respiration (LEAKGM) was slightly, but significantly increased
following KYNA therapy in the cerebellum.
Similarly, reduced complex II-dependent respirations were
found following the septic insult, and there was a significant
decrease in complex II-linked substrate oxidation (LEAKS) and
OXPHOS II capacity in the hippocampal and cerebellar regions
(Figures 7A, B). Remarkably, the treatments with KYNA, SZR-72
and SZR-104 improved LEAKS andOXPHOS II in the cerebellum.
Among the three compounds tested, only SZR-104 partially
restored complex II-linked OXPHOS in the hippocampus.DISCUSSION
The present study demonstrated the efficacy of KYNA and
KYNA analogue-based treatments in reducing BBB injury and
brain mitochondrial dysfunction during the early phases of
experimental intraabdominal sepsis. These changes may occur
due to NET-associated BBB injury. In this rodent model, proper
analgesia, fluid resuscitation and sequential assessment of organ
failure was performed according to the most recentFrontiers in Immunology | www.frontiersin.org 8recommendations (29). BBB change and brain injury were
associated with local neutrophil infiltration, which likely
coincided with systemic NET formation. In this scenario,
KYNA and its synthetic analogues only influenced a few
components of the ROFA score but exerted marked effects on
plasma and the cerebral tissue components of NET formation.
Further, the treatments significantly influenced sepsis-induced
BBB permeability changes and mitochondrial respiration in the
cerebellar and hippocampal regions.
Infiltration of immune cells into the CNS following BBB
injury causes myelin degradation and axonal damage (4), thus
underlining the importance of modulating BBB permeability
during systemic inflammation. In our model, S100B served not
only as a marker of astrocyte-derived brain injury but also as an
indicator of early BBB damage during sepsis (8). In this model, a
diffuse BBB dysfunction can be presumed because EB
accumulation (a good indicator of macromolecular passage
through the BBB), occurred in both the hippocampal and
cerebellar regions. KYNA and KYNA analogues differentially
affected these changes due to their different BBB penetration
abilities. Unlike both synthetic analogues, KYNA poorly
penetrates the BBB under normal physiological conditions (27,A
B
FIGURE 6 | Complex I-linked mitochondrial oxygen consumption in the
cerebellum (A) and the hippocampus (B) in the sham-operated group and in
the different sepsis groups treated with saline, KYNA, SZR-72 and SZR-104.
The plots demonstrate the median (horizontal line in the box) and the 25th
(lower whisker) and 75th (upper whisker) percentiles. One-way ANOVA, Holm–
Sidak post-hoc test; *P < 0.05 vs. sham-operated group; xP < 0.05 vs.
sepsis+saline group.A
B
FIGURE 7 | Complex II-linked mitochondrial oxygen consumption in the
cerebellum (A) and the hippocampus (B) in the sham-operated group and in
the different sepsis groups treated with saline, KYNA, SZR-72 and SZR-104.
The plots demonstrate the median (horizontal line in the box) and the 25th
(lower whisker) and 75th (upper whisker) percentiles. One-way ANOVA, Holm–
Sidak post-hoc test; *P < 0.05 vs. sham-operated group; xP < 0.05 vs.
sepsis+saline group.August 2021 | Volume 12 | Article 717157
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favored the penetration of all the compounds into the CNS at the
time of the treatments (16h and 22h of sepsis). Both KYNA and
SZR-104 significantly reduced (the latter more effectively) the
sepsis-induced increase in S100B plasma levels. Recently, a link
between NMDA-R and organization of the cytoskeleton in
regulating BBB permeability causing reduced S100B release
(32) and a shrinkage of brain endothelial cells via the
cytoskeletal reorganization (via a NMDA-R triggered Rho-
associated and a protein kinase-dependent phosphorylation of
the myosin light chain) were also described (33). Therefore, the
positive effect of SZR-104 on BBB integrity may also occur
through the inhibition of NMDA-R-dependent signaling
pathways (28).
A l ink between BBB damage and intravascular/
intraparenchymal NET formation in the CNS has already been
suggested (34), and reduced BBB damage as a consequence of
neutrophil depletion has also been demonstrated (9). Since
KYNA and KYNA analogues modulated NET components and
inhibited neutrophil accumulation (and their potential-tissue
damaging effects related to MPO and NADPH oxidase) in the
brain, a causal relationship between ameliorated BBB function
and attenuated NETosis is very likely. This assumption was
supported by the strong correlation (Spearman coefficient;
r=0.806; P<0.001) found between plasma CitH3 and plasma
S100B levels in septic rats (Supplementary Figure S3).
NET formation/NETosis is a systemic phenomenon which
plays a role in the pathogenesis of sepsis-associated organ
dysfunction (35). Although numerous variable components of
NETs have been identified, some structural elements of NETs are
consistent and comprehensive biomarkers (13). Levels of many
circulating NET markers (including plasma MPO, CitH3,
circulating cell-free DNA-histone complexes) and NET
inducers (IL-1b and interleukin-8; IL-8) increase under various
inflammatory conditions (36, 37). Among these, CitH3 is highly
specific to NET formation, and it was also suggested as a
therapeutic target in experimental models of sepsis (38, 39).
CitH3, together with its generating enzymes, peptidylarginine
deiminases, was implicated in accelerating thrombotic processes
(40), and their levels correlated with SOFA scores, disease
severity and ICU mortality in septic shock patients (41, 42). In
our study, apart from elevations in CitH3 plasma levels, plasma
levels of the NET-inducer IL-1b and the neutrophil-derived
MPO in plasma and brain tissues were also markedly increased
in septic rats. The sepsis-induced increases in MPO and CitH3
levels in plasma were significantly reduced by KYNA and its
analogues, and IL-1b plasma levels were also positively
influenced by SZR-104.
The effects of KYNA and its analogues on neutrophil-
dependent NET markers in the periphery and the CNS were
first examined in our study. The more detailed mechanism of
action calls for further investigations, but a concurrently reduced
release of pro-inflammatory cytokines (tumor necrosis factor
alpha (TNF-a); high mobility group box 1 (HMGB1) and IL-1b)
cannot be ruled out, as shown in other studies (43–45).
Previously, reduced tissue MPO and plasma pro-inflammatoryFrontiers in Immunology | www.frontiersin.org 9markers (TNF-a, IL-6) were also demonstrated in response to
KYNA and SZR-72 treatments in experimental colitis (24).
Activated platelets induce extracellular trap formation via
HMGB1 (46), and the role of HMGB1 in facilitating NETosis
and mediating brain injury has also been demonstrated (47). An
inhibitory effect of KYNA and SZR-72 on human mononuclear
cell-derived TNF-a and HMGB1 production represents another
pathway for the anti-inflammatory action of these compounds
(48). In addition, IL-1b activation has been shown to drop
following pretreatment with SZR-72 in a rat model of
Complete Freund’s Adjuvant-induced dural inflammation (45).
It is therefore plausible that KYNA and its derivatives inhibit
NET formation during sepsis through the inhibition of TNF-a
and HMGB1 release and IL-1b activation.
Crosstalk between mitochondria and NETosis has recently
been emphasized. Vorobjeva et al. demonstrated that the calcium
(Ca2+)-triggered opening of mitochondrial permeability
transition pores (mPTPs) stimulated mitochondrial ROS
production (mtROS), which in turn activated NET formation
independently of NADPH oxidase and MPO in neutrophil
leukocytes (49). On the other hand, NETs cause a reduction in
the capillary–mitochondrial oxygen gradient by enhancing the
formation of occluding thrombi (40), thereby impairing
mitochondrial respiration. As regards organelle function,
imbalance in mitochondrial homeostasis has previously been
demonstrated in the liver after sepsis, and it was effectively
reduced by KYNA and SZR-72 administration (17).
Our study has also shown that brain mitochondria are
affected early after the septic insult, with a decrease in
substrate (LEAKGM and LEAKS) and ADP-activated
respiration (OXPHOS) in cerebellar and hippocampal samples.
These findings support previous reports on a decrease in
mitochondrial activity (complex I) and enhanced ROS
production in different brain regions following CLP-induced
sepsis (16). One regulatory mechanism of OXPHOS machinery
can be mediated through phosphorylation/dephosphorylation of
respiratory chain proteins executed by opposing actions of
tyrosine kinase Src and protein tyrosine phosphatase 1B
(PTP1B). Sepsis or LPS stimuli initiate a pathologic imbalance
between Src/PTP1B activities (decreased Src and increased
PTP1B) that can ultimately reduce ATP synthesis in the brain
(3, 50). Moreover, energy metabolism can also be reprogrammed
from OXPHOS to aerobic glycolysis in microglial cells, resulting
in less net gain energy production per glucose (15).
In our experiments, KYNA and KYNA derivative-based
therapies ameliorated complex II-linked OXPHOS capacities
and substrate-activated respiration in cerebellum samples. This
finding is also consistent with other studies, in which KYNA
improved various mitochondrial parameters, such as complex II
activity, mitochondrial mass and membrane potential, antioxidant
enzyme levels, and ROS against quinolinic acid-induced neuronal
injury (51). There is also evidence that KYNA acting on G protein-
coupled receptor GPR35 regulates adipocyte energy homeostasis
via stimulation of lipid metabolism and mitochondrial respiration
(52). Additionally, NMDA-Rs were shown to be present in the
inner mitochondrial membrane (53), where they may play aAugust 2021 | Volume 12 | Article 717157
Poles et al. Kynurenic Acid-Based Sepsis Therapyregulatory role in Ca2+ transport. Inhibitory action exhibited by
KYNA or its synthetic analogues on NMDA-R may reduce (I)
receptor-driven Ca2+ influx, (II) mitochondrial Ca2+ overload and
(III) release of apoptosis inducer cytochrome c (54). Although
KYNA-mediated cell- and mito-protective properties were
identified in models of various diseases, KYNA itself did not
affect the bioenergetic function in the normal brain and normal
liver mitochondria (55).
The present study was first to describe the mitochondrial
effects of SZR-72 and SZR-104 in the CNS. Although only SZR-
104 ameliorated complex II-linked OXPHOS in the
hippocampus, all the treatments enhanced complex II-linked
OXPHOS in the cerebellum without affecting complex I
respiration. These differences may arise from the different
membrane localization of complexes I and II. Besides, complex
I is potentially more vulnerable to neuronal injury than other
ETS components, and the level of pyridine nucleotide and other
cofactors is also reduced during sepsis. There is also evidence
that the hippocampus is more susceptible to insults, such as
ischemia, anoxia, inflammation and sepsis (56). Therefore, a
functional difference in distinct brain regions, particularly after
BBB injury, cannot be ruled out. The mechanism by which SZR-
72 and SZR-104 preserve brain mitochondrial function is not yet
known with certainty; however, the microcirculatory
improvement can be mediated with different receptors
(NMDA-R and GPR35, respectively) (17). Better tissue
oxygenation along the capillary–mitochondrial oxygen gradient
may ameliorate oxygen consumption and subsequently results in
better energy production in the organelle (26).Frontiers in Immunology | www.frontiersin.org 10Our study has limitations as well. Firstly, the observation
period was relatively short; detection of other endpoints
(mortality or the cognitive component) would thus be needed
in longer follow-up studies. Only PAD-dependent NET
formation was addressed and plasma levels of CitH3 (and not
DNA-CitH3 complexes) were determined in our study, and the
number of inflammatory mediators (and NET inducers)
examined was also limited. Furthermore, the current design
did not allow us to investigate whether changes in BBB
permeability are transient or irreversible or involve
paracellular and/or transcellular pathways. The methodology
applied did not allow for an assessment of any causal
relationship between NET formation and BBB disintegration.
Likewise, the effects of the ketamine-containing anesthetic
agents cannot be disregarded. It should also be added that
since antibiotics affect mitochondrial functions, this
confounding option was purposefully omitted from the
protocol (57).
In conclusion, KYNA and its analogues on NET-associated
markers were first examined, and the compounds significantly
attenuated sepsis-induced leukocyte activation and alleviated
cerebral mitochondrial dysfunction. These compounds, either
via inhibition NMDA-R or NET formation, may influence BBB
permeability and mitochondrial damage, thereby reducing
sepsis-related brain injury (Figure 8). Alternatively, KYNA-
and analogue-based treatments may also affect tissue
oxygenation, and, as a consequence, they may improve
mitochondrial respiration. Our results suggest that KYNA or
synthetic derivatives, particularly SZR-104, might be applicableFIGURE 8 | Effects and potential targets of KYNA and its analogues. NMDA and GPR35 receptor-dependent mechanisms are highlighted. Gray arrows indicate the
literature-based mechanisms, and black arrows indicate the mechanisms examined in the study. BBB, blood–brain barrier; GPR35, G protein-coupled receptor 35;
KYNA, kynurenic acid; mPTP, mitochondrial permeability transition pore; mtROS, mitochondrial reactive oxygen species; NET, neutrophil extracellular trap; NMDA-R,
N-methyl-D-aspartate receptor; DYmt, mitochondrial membrane potential.August 2021 | Volume 12 | Article 717157
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Supplementary Figure 1 | Animal sickness assessment score in the sham-operated
group and in the different sepsis groups treated with saline, KYNA, SZR-72 and SZR-
104 taken 16h after sepsis induction. The plots demonstrate themedian (horizontal line in
the box) and the 25th (lower whisker) and 75th (upper whisker) percentiles. Kruskal–Wallis
test, Dunn’s post-hoc test; *P < 0.05 vs. sham-operated group.
Supplementary Figure 2 | Cerebellar (A) and hippocampal (B) wet weight/body
weight ratio in the sham-operated group and in the different sepsis groups treated with
saline, KYNA, SZR-72 and SZR-104. The plots demonstrate the median (horizontal
line in the box) and the 25th (lower whisker) and 75th (upper whisker) percentiles.
Kruskal–Wallis test, Dunn’s post-hoc test; *P < 0.05 vs. sham-operated group.
Supplementary Figure 3 | Correlation between plasma citrullinated histone H3
(CitH3) and plasma S100B values in septic rats. Spearman’s correlation coefficient r
values and (null hypothesis-related) P values are provided, regression line and 95%
confidence interval are indicated.REFERENCES
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CA, et al. Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-
Induced Toxicity in Rat Striatal Slices. Mol Neurobiol (2018) 55:8538–49.
doi: 10.1007/s12035-018-1003-2
52. Agudelo LZ, Ferreira DMS, Cervenka I, Bryzgalova G, Dadvar S, Jannig PR,
et al. Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy
Homeostasis and Inflammation. Cell Metab (2018) 27:378–92.e5.
doi: 10.1016/j.cmet.2018.01.004August 2021 | Volume 12 | Article 717157
Poles et al. Kynurenic Acid-Based Sepsis Therapy53. Nesterov SV, Skorobogatova YA, Panteleeva AA, Pavlik LL, Mikheeva IB,
Yaguzhinsky LS, et al. NMDA and GABA Receptor Presence in Rat Heart
Mitochondria. Chem Biol Interact (2018) 291:40–6. doi: 10.1016/j.cbi.2018.06.004
54. Ma T, Cheng Q, Chen C, Luo Z, Feng D. Excessive Activation of NMDA
Receptors in the Pathogenesis of Multiple Peripheral Organs Via
Mitochondrial Dysfunction, Oxidative Stress, and Inflammation. SN Compr
Clin Med (2020) 2:551–69. doi: 10.1007/s42399-020-00298-w
55. Baran H, Staniek K, Bertignol-Spörr M, Attam M, Kronsteiner C, Kepplinger
B. Effects of Various Kynurenine Metabolites on Respiratory Parameters of
Rat Brain, Liver and Heart Mitochondria. Int J Tryptophan Res (2016) 9:17–
29. doi: 10.4137/IJTR.S37973
56. Yuan M, Yan DY, Xu FS, Zhao YD, Zhou Y, Pan LF. Effects of Sepsis on
Hippocampal Volume and Memory Function. World J Emerg Med (2020)
11:223–30. doi: 10.5847/wjem.j.1920-8642.2020.04.004
57. Moullan N, Mouchiroud L, Wang X, Ryu D, Williams EG, Mottis A, et al.
Tetracyclines Disturb Mitochondrial Function Across Eukaryotic Models: A
Call for Caution in Biomedical Research. Cell Rep (2015) 10:1681–91.
doi: 10.1016/j.celrep.2015.02.034Frontiers in Immunology | www.frontiersin.org 13Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
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